Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 123


A training-testing approach to the molecular classification of resected non-small cell lung cancer.

Yamagata N, Shyr Y, Yanagisawa K, Edgerton M, Dang TP, Gonzalez A, Nadaf S, Larsen P, Roberts JR, Nesbitt JC, Jensen R, Levy S, Moore JH, Minna JD, Carbone DP.

Clin Cancer Res. 2003 Oct 15;9(13):4695-704.


Diagnostic assay based on hsa-miR-205 expression distinguishes squamous from nonsquamous non-small-cell lung carcinoma.

Lebanony D, Benjamin H, Gilad S, Ezagouri M, Dov A, Ashkenazi K, Gefen N, Izraeli S, Rechavi G, Pass H, Nonaka D, Li J, Spector Y, Rosenfeld N, Chajut A, Cohen D, Aharonov R, Mansukhani M.

J Clin Oncol. 2009 Apr 20;27(12):2030-7. doi: 10.1200/JCO.2008.19.4134.


Increased expression of the LGALS3 (galectin 3) gene in human non-small-cell lung cancer.

Yoshimura A, Gemma A, Hosoya Y, Komaki E, Hosomi Y, Okano T, Takenaka K, Matuda K, Seike M, Uematsu K, Hibino S, Shibuya M, Yamada T, Hirohashi S, Kudoh S.

Genes Chromosomes Cancer. 2003 Jun;37(2):159-64.


Accurate classification of non-small cell lung carcinoma using a novel microRNA-based approach.

Bishop JA, Benjamin H, Cholakh H, Chajut A, Clark DP, Westra WH.

Clin Cancer Res. 2010 Jan 15;16(2):610-9. doi: 10.1158/1078-0432.CCR-09-2638.


Caveolins as tumour markers in lung cancer detected by combined use of cDNA and tissue microarrays.

Wikman H, Seppänen JK, Sarhadi VK, Kettunen E, Salmenkivi K, Kuosma E, Vainio-Siukola K, Nagy B, Karjalainen A, Sioris T, Salo J, Hollmén J, Knuutila S, Anttila S.

J Pathol. 2004 May;203(1):584-93.


[Non small cell lung cancer gene expression profiles by cDNA microarrays].

Ouyang QC, Hu CP, Shi LJ.

Hunan Yi Ke Da Xue Xue Bao. 2003 Feb 28;28(1):9-12. Chinese.


Novel transmembrane GTPase of non-small cell lung cancer identified by mRNA differential display.

Chung JG, Yeh KT, Wu SL, Hsu NY, Chen GW, Yeh YW, Ho HC.

Cancer Res. 2001 Dec 15;61(24):8873-9.


Smoking and cancer-related gene expression in bronchial epithelium and non-small-cell lung cancers.

Woenckhaus M, Klein-Hitpass L, Grepmeier U, Merk J, Pfeifer M, Wild P, Bettstetter M, Wuensch P, Blaszyk H, Hartmann A, Hofstaedter F, Dietmaier W.

J Pathol. 2006 Oct;210(2):192-204.


Increased expression of insulin-like growth factor-II messenger RNA-binding protein 1 is associated with tumor progression in patients with lung cancer.

Kato T, Hayama S, Yamabuki T, Ishikawa N, Miyamoto M, Ito T, Tsuchiya E, Kondo S, Nakamura Y, Daigo Y.

Clin Cancer Res. 2007 Jan 15;13(2 Pt 1):434-42.


Expression of N-acetylglucosaminyltransferase v is associated with prognosis and histology in non-small cell lung cancers.

Dosaka-Akita H, Miyoshi E, Suzuki O, Itoh T, Katoh H, Taniguchi N.

Clin Cancer Res. 2004 Mar 1;10(5):1773-9.


Gene expression profiling allows distinction between primary and metastatic squamous cell carcinomas in the lung.

Talbot SG, Estilo C, Maghami E, Sarkaria IS, Pham DK, O-charoenrat P, Socci ND, Ngai I, Carlson D, Ghossein R, Viale A, Park BJ, Rusch VW, Singh B.

Cancer Res. 2005 Apr 15;65(8):3063-71.


Casein kinase II alpha subunit and C1-inhibitor are independent predictors of outcome in patients with squamous cell carcinoma of the lung.

O-charoenrat P, Rusch V, Talbot SG, Sarkaria I, Viale A, Socci N, Ngai I, Rao P, Singh B.

Clin Cancer Res. 2004 Sep 1;10(17):5792-803.


Methylation discriminators in NSCLC identified by a microarray based approach.

Field JK, Liloglou T, Warrak S, Burger M, Becker E, Berlin K, Nimmrich I, Maier S.

Int J Oncol. 2005 Jul;27(1):105-11.


Tissue-wide expression profiling using cDNA subtraction and microarrays to identify tumor-specific genes.

Amatschek S, Koenig U, Auer H, Steinlein P, Pacher M, Gruenfelder A, Dekan G, Vogl S, Kubista E, Heider KH, Stratowa C, Schreiber M, Sommergruber W.

Cancer Res. 2004 Feb 1;64(3):844-56.


Key genes in lung cancer translational research: a meta-analysis.

Amelung JT, Bührens R, Beshay M, Reymond MA.

Pathobiology. 2010;77(2):53-63. doi: 10.1159/000278292.


Expression profiling of non-small cell lung carcinoma identifies metastatic genotypes based on lymph node tumor burden.

Hoang CD, D'Cunha J, Tawfic SH, Gruessner AC, Kratzke RA, Maddaus MA.

J Thorac Cardiovasc Surg. 2004 May;127(5):1332-41; discussion 1342.


Expression profiles of non-small cell lung cancers on cDNA microarrays: identification of genes for prediction of lymph-node metastasis and sensitivity to anti-cancer drugs.

Kikuchi T, Daigo Y, Katagiri T, Tsunoda T, Okada K, Kakiuchi S, Zembutsu H, Furukawa Y, Kawamura M, Kobayashi K, Imai K, Nakamura Y.

Oncogene. 2003 Apr 10;22(14):2192-205.


Identification by means of cDNA microarray analyses of gene expression modifications in squamous non-small cell lung cancers as compared to normal bronchial epithelial tissue.

Remmelink M, Mijatovic T, Gustin A, Mathieu A, Rombaut K, Kiss R, Salmon I, Decaestecker C.

Int J Oncol. 2005 Jan;26(1):247-58.


HER-2/neu protein expression and gene alteration in stage I-IIIA non-small-cell lung cancer: a study of 140 cases using a combination of high throughput tissue microarray, immunohistochemistry, and fluorescent in situ hybridization.

Tan D, Deeb G, Wang J, Slocum HK, Winston J, Wiseman S, Beck A, Sait S, Anderson T, Nwogu C, Ramnath N, Loewen G.

Diagn Mol Pathol. 2003 Dec;12(4):201-11.


Clinical validity of the lung cancer biomarkers identified by bioinformatics analysis of public expression data.

Kim B, Lee HJ, Choi HY, Shin Y, Nam S, Seo G, Son DS, Jo J, Kim J, Lee J, Kim J, Kim K, Lee S.

Cancer Res. 2007 Aug 1;67(15):7431-8.

Items per page

Supplemental Content

Support Center